| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/21/2011 | US7964646 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/21/2011 | US7964400 Immune potentiating compositions of cancer cells |
| 06/21/2011 | US7964397 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 06/21/2011 | US7964384 Endotoxin binding by lactic acid bacteria and bifidobacteria |
| 06/21/2011 | US7964374 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 06/21/2011 | US7964197 Pathogen for bacterial poultry disease |
| 06/21/2011 | US7963935 Microprojection array having a beneficial agent containing coating |
| 06/21/2011 | CA2618682C Viral polymerase inhibitors |
| 06/21/2011 | CA2591843C Oxidation resistant dentifrice compositions |
| 06/21/2011 | CA2577144C Alkynyl compounds as non-nucleoside reverse transcriptase inhibitors |
| 06/21/2011 | CA2527155C Cationic porphyrin derivatives and uses thereof |
| 06/21/2011 | CA2492775C Polyalkylene glycol acid additives |
| 06/21/2011 | CA2483562C Heterotricyclyl-6-alkylidene-penems as beta-lactamase inhibitors |
| 06/21/2011 | CA2483303C Cinnamic acid amides |
| 06/21/2011 | CA2474192C Nicotinamide derivates useful as p38 inhibitors |
| 06/21/2011 | CA2472341C Phosphorus-containing compounds & uses thereof |
| 06/21/2011 | CA2472188C Polymeric gel system for the controlled delivery of codrugs |
| 06/21/2011 | CA2435681C Multivalent meningococcal polysaccharide-protein conjugate vaccine |
| 06/21/2011 | CA2405547C Protective agent against reinfection after liver transplantation |
| 06/21/2011 | CA2386019C Methods related to immunostimulatory nucleic acid-induced interferon |
| 06/21/2011 | CA2370323C Preparation for veterinary use for the prevention of ear diseases |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/21/2011 | CA2345079C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 06/21/2011 | CA2297408C Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof |
| 06/21/2011 | CA2288222C Oligonucleotide mediated specific cytokine induction and in vivo protection from infection |
| 06/21/2011 | CA2258735C Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus |
| 06/21/2011 | CA2199474C Inhibitory or blocking agents of molecular generating and/or inducing functions |
| 06/16/2011 | WO2011072287A2 Method for late introduction of the (8r)-hydroxyl group in carbapenem beta-lactam antibiotic synthesis |
| 06/16/2011 | WO2011072138A2 Therapeutic use of protein-polymer conjugates |
| 06/16/2011 | WO2011071981A2 Anti-cytomegalovirus activity of artemisinin-derived dimers |
| 06/16/2011 | WO2011071904A2 Inhibiting bacterial infection and biofilm formation |
| 06/16/2011 | WO2011071849A2 Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications |
| 06/16/2011 | WO2011071137A1 Therapeutic system for onychomycosis |
| 06/16/2011 | WO2011071134A1 Prophylactic composition for influenza infection |
| 06/16/2011 | WO2011070533A1 Peptides and their derivatives inhibiting extracellular release of hiv-1 tat protein and hiv-1 replication |
| 06/16/2011 | WO2011070369A1 Inhibitors of hemopoietic cell kinase (p59-hck) and their use in the treatment of influenza infection |
| 06/16/2011 | WO2011070364A1 Novel cyclic peptides |
| 06/16/2011 | WO2011070152A2 Novel antiviral compounds, which are aryl 3-deazauridine analogues at c3 position |
| 06/16/2011 | WO2011070131A1 5-amino- 4-hydroxypentoyl amides |
| 06/16/2011 | WO2011070032A1 Arenicin-3 for use in the treatment of urinary tract infections |
| 06/16/2011 | WO2011069990A1 Pharmaceutical or veterinary antiviral compositions |
| 06/16/2011 | WO2011069916A1 Triazole compounds, use thereof as a fungicide, and agents comprising same |
| 06/16/2011 | WO2011069860A1 Novel use for the treatment of metabolic endotoxemia |
| 06/16/2011 | WO2011069408A1 Polypeptide immunogen, preparation method and use thereof |
| 06/16/2011 | WO2011069335A1 Use of pyridines compounds in preparing rna interference reinforcing agent |
| 06/16/2011 | WO2011069322A1 Acyclic nucleoside phosphonate derivative and medicine use thereof |
| 06/16/2011 | WO2011069280A1 Antimicrobial pexiganan analogue and preparation process thereof |
| 06/16/2011 | WO2011069227A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof |
| 06/16/2011 | WO2011069184A1 Composition for treating skin lesions |
| 06/16/2011 | WO2011045703A3 C-linked hydroxamic acid derivatives useful as antibacterial agents |
| 06/16/2011 | WO2011044501A3 Antibacterial aminoglycoside analogs |
| 06/16/2011 | WO2011039735A3 Compounds with ddx3 inhibitory activity and uses thereof |
| 06/16/2011 | WO2011039221A3 Phosphoramidate derivatives of nucleosides |
| 06/16/2011 | WO2011036560A3 Glycoconjugate compositions and methods for treatment of hiv |
| 06/16/2011 | WO2011022509A3 Substituted benzoazepines as toll-like receptor modulators |
| 06/16/2011 | WO2011019932A9 Compositions and methods for the therapy and diagnosis of influenza |
| 06/16/2011 | WO2011009039A3 Pharmaceutical for oral delivery comprising mgbg and methods of treating disease |
| 06/16/2011 | US20110145941 Antibodies and derivatives thereof |
| 06/16/2011 | US20110144309 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 06/16/2011 | US20110144214 Hydroalcoholic gel compositions for use with dispensers |
| 06/16/2011 | US20110144204 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same |
| 06/16/2011 | US20110144184 Preventing or treating viral infection using an inhibitor of the lsd1 protein, a mao inhibitor or an inhibitor of lsd1 and a mao inhibitor |
| 06/16/2011 | US20110144171 Thiopene containing analogues of fluconazole as antifungal agents and process for their preparation |
| 06/16/2011 | US20110144169 Inhibitors of cellular necrosis |
| 06/16/2011 | US20110144158 Isoindole-imide compounds and compositions comprising and methods of using the same |
| 06/16/2011 | US20110144154 Salts of 2-Substituted Quinolines |
| 06/16/2011 | US20110144151 Novel process, salts, composition and use |
| 06/16/2011 | US20110144143 pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
| 06/16/2011 | US20110144134 Anti-Inflammatory Pyrazolopyrimndines |
| 06/16/2011 | US20110144118 Antiviral salts |
| 06/16/2011 | US20110144115 Substituted 1-benzyl-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 06/16/2011 | US20110144109 Derivatives of 1--4-methylpiperazine, synthesis process and uses thereof |
| 06/16/2011 | US20110144101 Macrocyclic compounds useful as pharmaceuticals |
| 06/16/2011 | US20110144099 Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| 06/16/2011 | US20110144074 Caspase inhibitors and uses thereof |
| 06/16/2011 | US20110144069 Compounds for treating viral infections |
| 06/16/2011 | US20110144050 Salts of hiv inhibitor compounds |
| 06/16/2011 | US20110144048 Novel Uses of Neuraminidase Inhibitors in Infectious Diseasess |
| 06/16/2011 | US20110144042 Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative |
| 06/16/2011 | US20110144040 Acteoside and acteoside-rich plant extracts for increasing athletic performance in humans |
| 06/16/2011 | US20110144039 Antioxidative and hepatoprotective compositions containing diaryheptanoids from alnus japonica |
| 06/16/2011 | US20110144020 Treatment of infections and other disorders |
| 06/16/2011 | US20110144005 Novel cyclic peptides |
| 06/16/2011 | US20110144004 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 06/16/2011 | US20110144002 Use of AMPs for Treatment of UTI/Cystitis |
| 06/16/2011 | US20110144001 Highly bridged peptides from actinomadura namibiensis |
| 06/16/2011 | US20110144000 Antimicrobial polypeptide |
| 06/16/2011 | US20110143999 Fowlicidins and methods of its use |
| 06/16/2011 | US20110143998 Identification and use of peptide inhibitors of protein synthesis |
| 06/16/2011 | US20110143997 Phage receptor binding proteins for antibacterial therapy and other novel uses |
| 06/16/2011 | US20110143996 Antimicrobial kinocidin compositions and methods of use |
| 06/16/2011 | US20110143992 Methods and Compositions Related to GHS-R Antagonists |
| 06/16/2011 | US20110142948 Nanoparticle Carrier Systems based on Human Serum Albumin for Photodynamic Therapy |
| 06/16/2011 | US20110142924 Irilis biopreparation based on bacillus-strain bacteria, bacillus subtilis and bacillus licheniformis contained therein |
| 06/16/2011 | US20110142921 NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION |
| 06/16/2011 | US20110142918 Anti-angiogenic compositions and therapeutic applications thereof |
| 06/16/2011 | US20110142916 Adjuvants for Use in Vaccination |
| 06/16/2011 | US20110142914 Inhalable compositions having enhanced bioavailability |
| 06/16/2011 | US20110142912 Non-specific immunostimulating agents |
| 06/16/2011 | US20110142911 HIV epitopes and pharmaceutical composition containing same |